Doctors step into virtual exam room to test genetic dosing decisions
NCT ID NCT02108041
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at how doctors make decisions about dosing the blood thinner warfarin based on a patient's genetic background. Researchers used virtual reality to simulate patient visits with different racial and socioeconomic backgrounds. 196 internal medicine residents participated in the 60-minute session. The goal was to understand how personalized medicine is used in practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help train doctors to better use genetic testing for personalized drug dosing.
What could go wrong
This is a small, completed observational study with healthy doctors in a virtual setting, not a real patient trial. Results may not reflect actual clinical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University
New York, New York, 10032-3784, United States
-
Harvard School of Public Health
Boston, Massachusetts, 02115, United States
-
Johns Hopkins School of Medicine
Baltimore, Maryland, 21205, United States
-
Michigan State University
Flint, Michigan, United States
-
University of Oregon
Eugene, Oregon, United States